BioSpace News Archive

BIOLASE, Inc., the global leader in dental lasers, announced its financial results for the first quarter ended March 31, 2022.

“With the accelerated FDA approval and U.S. commercial launch of VONJO, the first quarter was transformational for CTI and the myelofibrosis community.

Silverback Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2022 and provided a business update.

Amylyx Pharmaceuticals, Inc. reported financial results for the quarter ended March 31, 2022. “We are encouraged by the overall progress Amylyx made over the first quarter of 2022.

NovaBay® Pharmaceuticals, Inc. reports financial results for the three months ended March 31, 2022 and provides a business update.

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology therapies, announced financial results for the three-month period ended March 31, 2022 and provided a corporate update.

Equillium, Inc. announced financial results for the first quarter 2022 and provided an update on its corporate development and clinical programs.

Modular Medical, Inc. announced that Jeb Besser, CEO, is scheduled to present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022 at 1:00 p.m. ET.

Eledon Pharmaceuticals, Inc., a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, reported its first quarter 2022 operating and financial results.

Biotechnology company Zymergen Inc., reported preliminary financial results for the first quarter ended March 31, 2022.